Picoplatin CAS NO.181630-15-9

Shipping

Company information

Picoplatin is a platinum-based chemotherapy drug that is an analog of cisplatin. Its chemical structure includes a picoline (a derivative of pyridine) group, which is intended to enhance its effectiveness and reduce side effects compared to other platinum-based drugs.

Key Points about Picoplatin:

1. Mechanism of Action: Like other platinum-based drugs, Picoplatin works by forming cross-links with DNA in cancer cells, which inhibits DNA replication and leads to cell death. This action helps to slow down or stop the growth of tumors.

2. Therapeutic Use: Picoplatin is primarily investigated for its use in treating various types of cancer, including lung cancer, prostate cancer, and colorectal cancer. Clinical trials have been conducted to evaluate its efficacy and safety in these settings.

3. Advantages: The inclusion of the picoline group in Picoplatin’s structure is designed to improve its activity against certain types of cancer cells and potentially reduce some of the common side effects associated with cisplatin, such as nephrotoxicity (kidney damage) and peripheral neuropathy (nerve damage).

4. Development Status: As of the latest updates, Picoplatin has been in various stages of clinical trials to assess its effectiveness and safety. It is not as widely used or approved as cisplatin, but it represents an area of ongoing research in cancer treatment.

Overall, Picoplatin is part of the broader effort to develop more effective and less toxic chemotherapy options for cancer patients.